Capstone Investment Advisors
CLBT icon

Capstone Investment Advisors’s Cellebrite CLBT Stock Holding History

Capstone Investment Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-78,511
Closed -$870K – 2138
2024
Q1 		$870K Buy
+78,511
New +$801K ﹤0.01% 1233

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
CC
Crosslink Capital Menlo Park, California $1.35B AUM 35.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capstone Investment Advisors's CLBT Position: Q2 2024 in Review

Capstone Investment Advisors sold out of Cellebrite (CLBT) in Q2 2024, closing a stake of 78,511 shares — an estimated $870K sold.

Capstone Investment Advisors first reported a position in CLBT in Q1 2024 and held it in 1 quarter. The position peaked at $870K in Q1 2024. 148 funds tracked by Wall St. Rank hold CLBT as of Q2 2024.

  • Capstone Investment Advisors reported no remaining Cellebrite position as of Q2 2024 after selling out during the quarter.
  • Capstone Investment Advisors sold 78,511 Cellebrite shares in Q2 2024, an estimated $870K.
  • Capstone Investment Advisors first reported a position in Cellebrite in Q1 2024 and held it in 1 quarter.
  • Capstone Investment Advisors's Cellebrite position peaked at $870K in Q1 2024.
  • 148 funds tracked by Wall St. Rank held Cellebrite as of Q2 2024.

Based on Capstone Investment Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.